Former President Trump’s Presidential Federal Advisory Committee for COVID-19 needs to be reestablished under President Biden.
The United States Senate HELP Committee will hold a hearing tomorrow to officially begin the process of formulating legislation to strengthen our pandemic preparation and response. As a first step the committee will examine lessons learned from COVID-19. The committee took the unusual step of requesting written public comment and posting both an outline and working draft of the proposed legislation.
The legislative outline describes the formulation of a bipartisan Task Force to examine the emergence of SARS-CoV-2, and the United States’ Preparation
Kevin Kavanagh, MD
and Response to COVID-19. In addition, there are provisions regarding the functioning of the Centers for Disease Control and Prevention (CDC) and appointment of the CDC Director. There are provisions to improve local, state, and federal public health responses, along with addressing social disparities. Further provisions are designed to improve and modernize biosurveillance, data reporting, sharing and dissemination, and to accelerate research development of counter measures. The national strategic stockpile and supply chain are addressed. Finally, there are provisions to modernizing clinical trials and streamlining drug and vaccine development and review.
All of these provisions focus on acronyms of the CDC, FDA, BARDA, ASPR, NIAID and the GAO. What is missing is OSHA and frontline worker protection, this includes infection preventionists. This was the focus of the written public comment submitted by Health Watch USA (of which the author is the founder and president). A new Title (Title VI) was proposed which would address frontline worker safety:
This comment also called for augmenting the CDC’s authority to investigate outbreaks in consultation with local and state health departments. And to eliminate outside conflicts of interest created by non-governmental sources of CDC funding (i.e., CDC Foundation).
Previously on January 15, 2022, a letter was sent by Health Watch USA, the Massachusetts Nurses Association, and National Nurses United to the White House and faxed to Senator Mitch McConnell’s and Senator Chuck Schumer’s(9) offices, requesting that an independent Presidential Federal Advisory Committee for COVID-19 be reestablished under the Biden Administration.
The United States’ COVID-19 response is among the worst of highly developed nations. We can and need to do better. I feel the above will provide an outline for the U.S. to embark in a new direction and achieve optimal pandemic preparedness and response.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.